I-123 Iofetamine SPECT scan in children with neurological disorders
Journal Article
·
· Wisconsin Medical Journal; (USA)
OSTI ID:6170040
- Medical College of Wisconsin, Milwaukee (USA)
I-123 Iofetamine (IMP) single photon emission computed tomography (SPECT) imaging of the brain in 42 patients (ages 14 days to 23 years) was compared with other localizing studies in children with neurological diseases. All had an EEG and at least one imaging study of the brain (computed tomography (CT) or magnetic resonance imaging (MRI), or both). Seventy-eight percent of the patients had an EEG within 24-72 hours of the IMP-SPECT scan. Thirty-five (83%) had a history of seizures, and the remainder had other neurological conditions without a history of seizures. In most cases, a normal EEG reading with normal CT or MRI result predicted a normal SPECT study. When the EEG was abnormal the majority of the IMP-SPECT scans were abnormal and localized the abnormality to the same region. A comparison with CT and MRI showed that structural abnormalities involving the cortex were usually well demonstrated with IMP-SPECT imaging. Structural lesions confined to the white matter were generally not detectable with IMP-SPECT. In a few cases, SPECT scans revealed abnormalities in deep brain areas not identified by EEG. IMP-SPECT imaging is a valuable technique for the detection and localization of abnormal cerebral metabolic activity in children with seizure disorders. A correlation with CT or MRI is essential for proper interpretation of abnormalities detected with IMP SPECT imaging.
- OSTI ID:
- 6170040
- Journal Information:
- Wisconsin Medical Journal; (USA), Journal Name: Wisconsin Medical Journal; (USA) Vol. 89:10; ISSN 0043-6542; ISSN WMJOA
- Country of Publication:
- United States
- Language:
- English
Similar Records
I-123 iofetamine single photon emission tomography in school-age children with difficult-to-control seizures
Hemimegalencephaly: Clinical, EEG, neuroimaging, and IMP-SPECT correlation
Iofetamine hydrochloride I 123: a new radiopharmaceutical for cerebral perfusion imaging
Journal Article
·
Fri Sep 01 00:00:00 EDT 1989
· Clinical Nuclear Medicine; (USA)
·
OSTI ID:5261478
Hemimegalencephaly: Clinical, EEG, neuroimaging, and IMP-SPECT correlation
Journal Article
·
Wed Oct 31 23:00:00 EST 1990
· Pediatric Neurology; (USA)
·
OSTI ID:5919194
Iofetamine hydrochloride I 123: a new radiopharmaceutical for cerebral perfusion imaging
Journal Article
·
Sat Dec 31 23:00:00 EST 1988
· DICP; (United States)
·
OSTI ID:5903823
Related Subjects
550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
ADOLESCENTS
AGE GROUPS
BETA DECAY RADIOISOTOPES
BODY
BRAIN
CENTRAL NERVOUS SYSTEM
CHILDREN
COMPUTERIZED TOMOGRAPHY
COUNTING TECHNIQUES
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
EMISSION COMPUTED TOMOGRAPHY
HOURS LIVING RADIOISOTOPES
INFANTS
INTERMEDIATE MASS NUCLEI
IODINE 123
IODINE ISOTOPES
ISOTOPES
NERVOUS SYSTEM
NERVOUS SYSTEM DISEASES
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PATIENTS
RADIOISOTOPE SCANNING
RADIOISOTOPES
SCINTISCANNING
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY
TOMOGRAPHY
62 RADIOLOGY AND NUCLEAR MEDICINE
ADOLESCENTS
AGE GROUPS
BETA DECAY RADIOISOTOPES
BODY
BRAIN
CENTRAL NERVOUS SYSTEM
CHILDREN
COMPUTERIZED TOMOGRAPHY
COUNTING TECHNIQUES
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
EMISSION COMPUTED TOMOGRAPHY
HOURS LIVING RADIOISOTOPES
INFANTS
INTERMEDIATE MASS NUCLEI
IODINE 123
IODINE ISOTOPES
ISOTOPES
NERVOUS SYSTEM
NERVOUS SYSTEM DISEASES
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PATIENTS
RADIOISOTOPE SCANNING
RADIOISOTOPES
SCINTISCANNING
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY
TOMOGRAPHY